Price Alert

NewAmsterdam Pharma N.V. (NAMSW)

NASDAQ: NAMSW · Real-Time Price · USD

13.80

0.00 (0.00%)

At close: Aug 15, 2025, 2:27 PM

13.80

0.00%

After-hours: Aug 15, 2025, 04:00 PM EDT

NewAmsterdam Pharma Statistics

Share Statistics

NewAmsterdam Pharma has 223.92M shares outstanding. The number of shares has increased by 0.36% in one year.

Shares Outstanding	223.92M
Shares Change (YoY)	0.36%
Shares Change (QoQ)	-8.04%
Owned by Institutions (%)	n/a
Shares Floating	119.54M
Failed to Deliver (FTD) Shares	n/a
FTD / Avg. Volume	n/a

Short Selling Information

Short Interest	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	71.91
Forward PS	n/a
PB Ratio	3.18
P/FCF Ratio	n/a
PEG Ratio	undefined

Financial Ratio History

Enterprise Valuation

NewAmsterdam Pharma has an Enterprise Value (EV) of 577.36M.

EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 6.95, with a Debt / Equity ratio of undefined.

Current Ratio	6.95
Quick Ratio	6.95
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	undefined

Financial Efficiency

Return on Equity is -0.61% and Return on Invested Capital is -57.46%.

Return on Equity	-0.61%
Return on Assets	-0.51%
Return on Invested Capital	-57.46%
Revenue Per Employee	$205.85K
Profits Per Employee	$-2.85M
Employee Count	62
Asset Turnover	0.04
Inventory Turnover	n/a

Taxes

Income Tax	27K
Effective Tax Rate	0%

Stock Price Statistics

The stock price has increased by null% in the last 52 weeks. The beta is 0, so NewAmsterdam Pharma's price volatility has been lower than the market average.

Beta	0
52-Week Price Change	n/a
50-Day Moving Average	12.02
200-Day Moving Average	9.59
Relative Strength Index (RSI)	35.07
Average Volume (20 Days)	n/a

Income Statement

In the last 12 months, NewAmsterdam Pharma had revenue of 12.76M and earned -176.94M in profits. Earnings per share was -2.15.

Revenue	12.76M
Gross Profit	12.76M
Operating Income	-165.73M
Net Income	-176.94M
EBITDA	-176.86M
EBIT	-165.73M
Earnings Per Share (EPS)	-2.15

Full Income Statement

Balance Sheet

The company has 340.45M in cash and 60K in debt, giving a net cash position of 340.39M.

Cash & Cash Equivalents	340.45M
Total Debt	60K
Net Cash	340.39M
Retained Earnings	-316.97M
Total Assets	439.19M
Working Capital	396.62M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -141.22M and capital expenditures -24K, giving a free cash flow of -141.24M.

Operating Cash Flow	-141.22M
Capital Expenditures	-24K
Free Cash Flow	-141.24M
FCF Per Share	-1.72

Full Cash Flow Statement

Margins

Gross margin is 100%, with operating and profit margins of -1298.56% and -1386.36%.

Gross Margin	100%
Operating Margin	-1298.56%
Pretax Margin	-1255.57%
Profit Margin	-1386.36%
EBITDA Margin	-1385.76%
EBIT Margin	-1298.56%
FCF Margin	-1106.68%

Dividends & Yields

NAMSW does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Payout Ratio	n/a
Earnings Yield	n/a
FCF Yield	n/a

Dividend Details

Analyst Forecast

Currently there are no analyst rating for NAMSW.

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Scores

Altman Z-Score	19.1
Piotroski F-Score	1